Change in Neuropsychological Test Performance Seen in a Longitudinal Study of Patients With Post-acute Sequelae of COVID-19: A 6-Month Follow-up Study

• Published in: Journal of the Academy of Consultation-Liaison Psychiatry Vol. 65; no. 3; pp. 231 - 247
• Main Authors: Lynch, Sean T., Dornbush, Rhea, Shahar, Sivan, Mansour, Rayah, Klepacz, Lidia, Primavera, Louis H., Ferrando, Stephen J.
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier Inc 01-05-2024
• Subjects: cognitive complaints; COVID-19; neuropsychiatry; neuropsychological testing; post-acute sequelae of COVID-19 (PASC); COVID-19; neuropsychiatry; neuropsychological testing; cognitive complaints; post-acute sequelae of COVID-19 (PASC)
• ISSN: 2667-2960; 2667-2960
• DOI: 10.1016/j.jaclp.2023.12.005

Post-acute sequelae of COVID-19 may include physical, psychiatric, and neurocognitive symptoms. Few studies of cognitive symptoms have been longitudinal, with many following participants briefly after infection and relying on subjective complaints, screening instruments, or computerized testing. This group previously reported diminished neuropsychological (NP) test performance in over half of 60 individuals tested in-person 7 months post-COVID-19, particularly those seeking care for cognitive complaints. The current study describes the initial and 6-month follow-up results of an expanded cohort of 75 participants.
To measure longitudinal changes in neuropsychological test performance, as well as medical and psychiatric changes, post-COVID-19.
Participants underwent NP, psychiatric, and medical assessments approximately 7 months after acute COVID-19 infection. Sixty-three (84%) returned approximately 6 months later for repeat evaluation.
At the initial visit, 29 (38.7%) met criteria for low NP performance, and 16 (21.3%) met criteria for extremely low NP performance. At 6-month follow-up, several NP domains that were significantly below normative values at the initial visit were no longer abnormal, with the exception of language. Only measures of delayed memory and fatigue showed significant improvements between the 2 time points.
A substantial proportion of individuals recovered from acute COVID-19 infection have persistent neuropsychiatric symptoms over 1 year after infection. While the overall sample in this study showed some improvement in NP test performance relative to norms, only fatigue and delayed memory improved significantly between times 1 and 2. No individual declined in NP test performance, though relatively few individuals made significant clinical improvement, indicating the need for serial neuropsychiatric assessment and treatment supports. Longitudinal follow-up of this cohort is in progress.